ADC Therapeutics SA
NYSE · CIK 0001771910 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | ADC Therapeutics SA | 2026-07-02 | 0001628280-26-047036 |
| 4 | ADC Therapeutics SA | 2026-07-02 | 0001628280-26-047034 |
| 4 | ADC Therapeutics SA | 2026-07-02 | 0001628280-26-047033 |
| 4 | ADC Therapeutics SA | 2026-07-02 | 0001628280-26-047031 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040493 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040492 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040491 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040490 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040489 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040488 |
| 4 | ADC Therapeutics SA | 2026-06-03 | 0001628280-26-040487 |
| 10-Q | ADC Therapeutics SA | 2026-05-04 | 0001628280-26-029819 |
| 4 | ADC Therapeutics SA | 2026-04-02 | 0001104659-26-039359 |
| 10-K | ADC Therapeutics SA | 2026-03-10 | 0001628280-26-016491 |
| 4 | ADC Therapeutics SA | 2026-02-18 | 0001628280-26-009283 |
| 4 | ADC Therapeutics SA | 2026-02-18 | 0001628280-26-009282 |
| 4 | ADC Therapeutics SA | 2026-02-18 | 0001628280-26-009280 |
| 4 | ADC Therapeutics SA | 2026-02-18 | 0001628280-26-009278 |
| 4 | ADC Therapeutics SA | 2026-02-18 | 0001628280-26-009275 |
| 4 | ADC Therapeutics SA | 2025-12-09 | 0001628280-25-056172 |
| 4 | ADC Therapeutics SA | 2025-12-09 | 0001628280-25-056171 |
| 4 | ADC Therapeutics SA | 2025-12-09 | 0001628280-25-056170 |
| 4 | ADC Therapeutics SA | 2025-12-09 | 0001628280-25-056169 |
| 4 | ADC Therapeutics SA | 2025-12-09 | 0001628280-25-056168 |
| 10-Q | ADC Therapeutics SA | 2025-11-10 | 0001628280-25-051095 |
| 10-Q | ADC Therapeutics SA | 2025-08-12 | 0001771910-25-000008 |